Functions of platelets in tumor growth and metastasis

Abstract

Zhang Tianjia, Dang Suying. Functions of platelets in tumor growth and metastasis[J]. Journal of International Oncology, 2014, 41(8): 645-647.

［1］ Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer［J］. J Clin Oncol, 2009, 27(29): 4839-4847. ［2］ Lyman GH, Khorana AA. Cancer, clots and consensus: new understanding of an old problem［J］. J Clin Oncol, 2009, 27(29): 4821-4826. ［3］ Bambace NM, Holmes CE. The platelet contribution to cancer progression［J］. J Thromb Haemost, 2011, 9(2): 237-249. ［4］ Gay LJ, FeldingHabermann B. Contribution of platelets to tumor metastasis［J］. Nat Rev Cancer, 2011, 11(2): 123-134. ［5］ Zhang W, Dang S, Hong T, et al. A humanized singlechain antibody against beta 3 integrin inhibits pulmonarymetastasis by preferentially fragmenting activated platelets in the tumor microenvironment［J］. Blood, 2012, 120(14): 2889-2898. ［6］ Rao AK, Rao DA. Platelets signal and tumors take off［J］. Blood, 2012, 120(24): 4667-4668. ［7］ Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelialmesenchymallike transition and promotes metastasis［J］. Cancer Cell, 2011, 20(5): 576-590. ［8］ Versteeg HH, Schaffner F, Kerver M, et al. Proteaseactivated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice［J］. Cancer Res, 2008, 68(17): 7219-7227. ［9］ Jain S, Zuka M, Liu J, et al. Platelet glycoprotein Ⅰb alpha supports experimental lung metastasis［J］. Proc Natl Acad Sci USA, 2007, 104(21): 9024-9028. ［10］ Kopp HG, Placke T, Salih HR. Plateletderived transforming growth factorbeta downregulates NKG2D thereby inhibiting natural killer cell antitumor reactivity［J］. Cancer Res, 2009, 69(19): 7775-7783. ［11］ Lubli H, Borsig L. Selectins promote tumor metastasis［J］. Semin Cancer Biol, 2010, 20(3): 169-177. ［12］ Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game［J］. Nat Rev Mol Cell Biol, 2010, 11(4): 288-300. ［13］ Kuo YC, Su CH, Liu CY, et al. Transforming growth factorbeta induces CD44 cleavage that promotes migration of MDAMB435s cells through the upregulation of membrane type 1matrix metalloproteinase［J］. Int J Cancer, 2009, 124(11): 2568-2576. ［14］ Smyth SS, McEver RP, Weyrich AS, et al. Platelet functions beyond hemostasis［J］. J Thromb Haemost, 2009, 7(11): 1759-1766. ［15］ HoTinNoé B, Goerge T, Cifuni SM, et al. Platelet granule secretion continuoussly prevents intratumor hemorrhage［J］. Cancer Res, 2008, 68(16): 6851-6858.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Functions of platelets in tumor growth and metastasis

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments